Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and ...

ORLYNVAH™ is a novel oral penem antibiotic for the treatment of uUTI ... or AmpC-type beta-lactamases that confer resistance to third generation cephalosporins.

The poster presented at ECCMID was ... About ORLYNVAH™ ORLYNVAH™ is a novel oral penem antibiotic for the treatment of uUTI. ORLYNVAH™ possesses potent activity against species of ...

Intellectual curiosity, passion, and collaboration combine at the annual Undergraduate Research Forum, allowing Miami ...

A meningitis outbreak is sweeping through Ghana’s Upper West region, exposing a struggling health care system. With ...

Under the National Antimicrobial Resistance Surveillance Network (NARS ... Awareness campaigns, including posters, videos, and radio jingles in 12 languages, have also been launched.

The poster presented at ECCMID was ... as experts raise concerns about antibiotic resistance. Iterum provides updates from the FDA's Antimicrobial Drugs Advisory Committee meeting on its NDA ...

According to BVA's Voice of the Veterinary Profession survey, antimicrobial resistance (AMR) is a top three concern ... organisations are encouraging vets and doctors to download the poster for their ...